Publications by authors named "Hannah Visca"

Claim this Profile
P
pHLIP targeted intracellular delivery of calicheamicin.
Michael DuPont, Craig Klumpp, Marissa Iraca, Dana Allababidi, Hannah Visca

Int J Pharm· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors.
Anna Moshnikova, Michael DuPont, Marissa Iraca, Craig Klumpp, Hannah Visca

Front Pharmacol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginine Residues Modulate the Membrane Interactions of pHLIP Peptides.
Tomás F D Silva, Hannah Visca, Craig Klumpp, Oleg A Andreev, Yana K Reshetnyak

J Chem Inf Model· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor treatment by pHLIP-targeted antigen delivery.
Michael DuPont, Hannah Visca, Anna Moshnikova, Donald M Engelman, Yana K Reshetnyak

Front Bioeng Biotechnol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pHLIP Peptides Target Acidity in Activated Macrophages.
Hannah Visca, Michael DuPont, Anna Moshnikova, Troy Crawford, Donald M Engelman

Mol Imaging Biol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP.
Anna Moshnikova, Michael DuPont, Hannah Visca, Donald M Engelman, Oleg A Andreev

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging of Acidic Tumor Environment With Zr-labeled pHLIP Probes.
David Bauer, Hannah Visca, Anuradha Weerakkody, Lukas M Carter, Zachary Samuels

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'.
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Hannah Visca

NAR Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity.
Sophia Gayle, Robert Aiello, Nalin Leelatian, Jason M Beckta, Jane Bechtold, Hannah Visca

NAR Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis